These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Use of specific serotonin uptake inhibitors as antidepressants. Lemberger L, Fuller RW, Zerbe RL. Clin Neuropharmacol; 1985; 8(4):299-317. PubMed ID: 2866836 [No Abstract] [Full Text] [Related]
44. Serotonin reuptake inhibition in the management of depression. Proceedings of a satellite symposium in connection with the VIII World Congress of Psychiatry. October 18, 1989, Athens, Greece. J Clin Psychiatry; 1990 Dec; 51 Suppl B():1-39. PubMed ID: 1979557 [No Abstract] [Full Text] [Related]
45. Reader response: Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study. Kawada T. Neurology; 2020 Aug 04; 95(5):231-232. PubMed ID: 32747463 [No Abstract] [Full Text] [Related]
46. Author response: Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study. Douros A, Boivin JF, Renoux C. Neurology; 2020 Aug 04; 95(5):232. PubMed ID: 32747464 [No Abstract] [Full Text] [Related]
49. The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain. Caccia S, Anelli M, Codegoni AM, Fracasso C, Garattini S. Br J Pharmacol; 1993 Sep 04; 110(1):355-9. PubMed ID: 7693282 [Abstract] [Full Text] [Related]
51. Rabbit syndrome, antidepressant use, and cerebral perfusion SPECT scan findings. Fornazzari L, Ichise M, Remington G, Smith I. J Psychiatry Neurosci; 1991 Nov 04; 16(4):227-9. PubMed ID: 1786266 [Abstract] [Full Text] [Related]
52. Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Murdoch D, McTavish D. Drugs; 1992 Oct 04; 44(4):604-24. PubMed ID: 1281075 [Abstract] [Full Text] [Related]
53. Pharmacological effects of serotonin reuptake inhibitors. Leonard BE. J Clin Psychiatry; 1988 Aug 04; 49 Suppl():12-7. PubMed ID: 3045106 [Abstract] [Full Text] [Related]
54. Pharmacologic properties of serotonergic agents and antidepressant drugs. Fuller RW. J Clin Psychiatry; 1987 Mar 04; 48 Suppl():5-11. PubMed ID: 3493240 [Abstract] [Full Text] [Related]
55. Antidepressants. Current concepts of mode of action. Léonard BE. Encephale; 1991 Mar 04; 17 Spec No 1():127-31. PubMed ID: 1677887 [Abstract] [Full Text] [Related]
56. [Mechanism of action of antidepressants and therapeutic perspectives]. Bourin M, David DJ, Jolliet P, Gardier A. Therapie; 2002 Mar 04; 57(4):385-96. PubMed ID: 12422559 [Abstract] [Full Text] [Related]
57. Serotonin reuptake blockers in vitro and in vivo. Fuller RW, Wong DT. J Clin Psychopharmacol; 1987 Dec 04; 7(6 Suppl):36S-43S. PubMed ID: 2828437 [Abstract] [Full Text] [Related]
58. Pharmacological effects of serotonin reuptake inhibitors. Leonard BE. J Clin Psychiatry; 1988 Aug 04; 49 Suppl():12-7. PubMed ID: 3045106 [Abstract] [Full Text] [Related]
59. Pharmacologic properties of serotonergic agents and antidepressant drugs. Fuller RW. J Clin Psychiatry; 1987 Mar 04; 48 Suppl():5-11. PubMed ID: 3493240 [Abstract] [Full Text] [Related]
60. Antidepressants. Current concepts of mode of action. Léonard BE. Encephale; 1991 Mar 04; 17 Spec No 1():127-31. PubMed ID: 1677887 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]